aibio
Financings ·
Vogenx prices IPO of 6,250,000 shares at $13.00 on Nasdaq
Vogenx priced 6,250,000 shares at $13.00, for $81,250,000 before underwriting discounts. The prospectus shows $251 thousand of cash at March 31, 2026 and a going-concern warning.
VOGX Vogenx Inc
Vogenx (VOGX) news VOGX going concern, IPO and offering news
Latest Vogenx news
- Financings
Vogenx files for IPO, plans Nasdaq Capital Market listing as VOGX
Vogenx filed a Form S-1 on July 15, 2026 for an initial public offering with the share count and price still blank. The filing reports $251 thousand of cash on March 31, 2026, and its financial statements carry going-concern doubt.
Questions about Vogenx
Has Vogenx issued a going-concern warning?
Our latest story on this, dated Aug 12, 2026: "Vogenx prices IPO of 6,250,000 shares at $13.00 on Nasdaq". The story links the filing or release it is based on. Read the story.
When did Vogenx go public?
Our latest story on this, dated Aug 12, 2026: "Vogenx prices IPO of 6,250,000 shares at $13.00 on Nasdaq". The story links the filing or release it is based on. Read the story.
Has Vogenx raised money recently?
Our latest story on this, dated Jul 15, 2026: "Vogenx files for IPO, plans Nasdaq Capital Market listing as VOGX". The story links the filing or release it is based on. Read the story.
What is the ticker symbol of Vogenx?
Vogenx Inc trades under the ticker VOGX on NASDAQ.
Where is Vogenx listed?
Vogenx Inc is listed on NASDAQ.
What is the SEC CIK of Vogenx?
The SEC Central Index Key (CIK) for Vogenx Inc is 1903784. Its filings are on SEC EDGAR.
How many shares does Vogenx have outstanding?
14,855,087 shares as of 2026-09-17, per the cover page of its 10-Q filed 2026-09-17.
Which country or territory is Vogenx listed under?
Our directory records Vogenx Inc under United States.
What does Vogenx do?
Our directory classifies Vogenx Inc as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.
What is the ISIN of Vogenx?
The ISIN recorded for Vogenx Inc is US92859A1060.
Does aibio.space cover Vogenx?
aibio.space lists Vogenx Inc among 2,820 public biotech companies and publishes its news here as stories appear.
Where is Vogenx incorporated?
SEC records list its state or country of incorporation as DE.
What is the latest Vogenx (VOGX) stock news?
Our latest story on Vogenx, dated Aug 12, 2026: "Vogenx prices IPO of 6,250,000 shares at $13.00 on Nasdaq". Vogenx priced 6,250,000 shares at $13.00, for $81,250,000 before underwriting discounts. The prospectus shows $251 thousand of cash at March 31, 2026 and a going-concern warning. Source.
How long will Vogenx's cash last?
From our story of Aug 12, 2026: The prospectus shows $251 thousand of cash at March 31, 2026 and a going-concern warning. Source.
Is Vogenx a smaller reporting company?
SEC records list Vogenx Inc's filer category as: <br>Emerging growth company.
Investor discussion: Vogenx
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
Stock chart
SEC filings and registration
- SEC name
- Vogenx, Inc.
- CIK
- 1903784
- Industry (SIC)
- Pharmaceutical Preparations (2834)
- US tickers
- VOGX (Nasdaq)
- State or country of incorporation
- DE
- Fiscal year ends
- December 31
- Filer category
- <br>Emerging growth company
- Business address
- 3901 BARRETT DRIVE, SUITE 300, RALEIGH, NC, 27609
- Phone
- 9196595677
- Shares outstanding
- 14,855,087 as of 2026-09-17 (10-Q filed 2026-09-17)
Recent filings
Listing details
- Company
- Vogenx Inc
- Ticker
- VOGX
- Listing
- NASDAQ
- Country or territory
- United States
- Business scope
- Pharmaceuticals: Major
- ISIN
- US92859A1060
- Last quote in directory
- 2026-10-21
- Directory source
- Listing page
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction